Market Research

Coagulation Testing Market (Product Type: Instruments and Consumables; and Test Type: Prothrombin Time, Activated Partial Thromboplastin Clotting Time, Thrombin Time, Activated Clotting Time, and Others) - Global Industry Analysis, Size, Share, Growth, Tr

Best Price Guarantee Length Publisher Published Date SKU
from $5,795 177 Pages Transparency Market Research Pvt. Ltd. April, 2024 TNPR18827813
Best Price Guarantee
Price from $5,795
Length 177 Pages
Publisher Transparency Market Research Pvt. Ltd.
Published Date April, 2024
SKU TNPR18827813

Coagulation Testing Market (Product Type: Instruments and Consumables; and Test Type: Prothrombin Time, Activated Partial Thromboplastin Clotting Time, Thrombin Time, Activated Clotting Time, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034


Coagulation Testing Market – Scope of Report

TMR’s report on the global coagulation testing market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global coagulation testing market for the period 2018–2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global coagulation testing market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the coagulation testing market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global coagulation testing market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global coagulation testing market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global coagulation testing market.

The report delves into the competitive landscape of the global coagulation testing market. Key players operating in the global coagulation testing market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global coagulation testing market profiled in this report.

Key Questions Answered in Global coagulation testing Market Report
  • What is the sales/revenue generated by coagulation testing across all regions during the forecast period?
  • What are the opportunities in the global coagulation testing market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?
Coagulation Testing Market – Research Objectives and Research Approach

The comprehensive report on the global coagulation testing market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global coagulation testing market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global coagulation testing market.


1. Preface
  1.1. Market Definition and Scope
  1.2. Market Segmentation
  1.3. Key Research Objectives
  1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Coagulation Testing Market
4. Market Overview
  4.1. Introduction
  4.1.1. Product Definition
  4.1.2. Industry Evolution/Developments
  4.2. Overview
  4.3. Market Dynamics
  4.3.1. Drivers
  4.3.2. Restraints
  4.3.3. Opportunities
  4.4. Coagulation Testing Market Analysis and Forecast, 2020-2034
5. Key Insights
  5.1. Pipeline Analysis
  5.2. Key Product /Brand Analysis
  5.3. Key Mergers & Acquisitions
  5.4. COVID-19 Pandemic Impact on Industry
6. Global Coagulation Testing Market Analysis and Forecast, by Product Type
  6.1. Introduction & Definition
  6.2. Key Findings/Developments
  6.3. Market Value Forecast, by Product Type, 2020-2034
  6.3.1. Instruments
  6.3.2. Consumables
  6.4. Market Attractiveness Analysis, by Product Type
7. Global Coagulation Testing Market Analysis and Forecast, by Test Type
  7.1. Introduction & Definition
  7.2. Key Findings/Developments
  7.3. Market Value Forecast, by Test Type, 2020-2034
  7.3.1. Prothrombin Time (PT)
  7.3.2. Activated Partial Thromboplastin Clotting Time (APTT)
  7.3.3. Thrombin Time (TT)
  7.3.4. Activated Clotting Time (ACT)
  7.3.5. Others
  7.4. Market Attractiveness Analysis, by Test Type
8. Global Coagulation Testing Market Analysis and Forecast, by End-user
  8.1. Introduction & Definition
  8.2. Key Findings/Developments
  8.3. Market Value Forecast, by End-user, 2020-2034
  8.3.1. Hospitals and Clinics
  8.3.2. Diagnostic Laboratories
  8.3.3. Home Care Settings
  8.3.4. Others
  8.4. Market Attractiveness Analysis, by End-user
9. Global Coagulation Testing Market Analysis and Forecast, by Region
  9.1. Key Findings
  9.2. Market Value Forecast, by Region, 2020-2034
  9.2.1. North America
  9.2.2. Europe
  9.2.3. Asia Pacific
  9.2.4. Latin America
  9.2.5. Middle East & Africa
  9.3. Market Attractiveness Analysis, by Region
10. North America Coagulation Testing Market Analysis and Forecast
  10.1. Introduction
  10.2. Key Findings
  10.3. Market Value Forecast, by Product Type, 2020-2034
  10.3.1. Instruments
  10.3.2. Consumables
  10.4. Market Value Forecast, by Test Type, 2020-2034
  10.4.1. Prothrombin Time (PT)
  10.4.2. Activated Partial Thromboplastin Clotting Time (APTT)
  10.4.3. Thrombin Time (TT)
  10.4.4. Activated Clotting Time (ACT)
  10.4.5. Others
  10.5. Market Value Forecast, by End-user, 2020-2034
  10.5.1. Hospitals and Clinics
  10.5.2. Diagnostic Laboratories
  10.5.3. Home Care Settings
  10.5.4. Others
  10.6. Market Value Forecast, by Country, 2020-2034
  10.6.1. U.S.
  10.6.2. Canada
  10.7. Market Attractiveness Analysis
  10.7.1. By Product Type
  10.7.2. By Test Type
  10.7.3. By End-user
  10.7.4. By Country
11. Europe Coagulation Testing Market Analysis and Forecast
  11.1. Introduction
  11.2. Key Findings
  11.3. Market Value Forecast, by Product Type, 2020-2034
  11.3.1. Instruments
  11.3.2. Consumables
  11.4. Market Value Forecast, by Test Type, 2020-2034
  11.4.1. Prothrombin Time (PT)
  11.4.2. Activated Partial Thromboplastin Clotting Time (APTT)
  11.4.3. Thrombin Time (TT)
  11.4.4. Activated Clotting Time (ACT)
  11.4.5. Others
  11.5. Market Value Forecast, by End-user, 2020-2034
  11.5.1. Hospitals and Clinics
  11.5.2. Diagnostic Laboratories
  11.5.3. Home Care Settings
  11.5.4. Others
  11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
  11.6.1. Germany
  11.6.2. U.K.
  11.6.3. France
  11.6.4. Italy
  11.6.5. Spain
  11.6.6. Rest of Europe
  11.7. Market Attractiveness Analysis
  11.7.1. By Product Type
  11.7.2. By Test Type
  11.7.3. By End-user
  11.7.4. By Country/Sub-region
12. Asia Pacific Coagulation Testing Market Analysis and Forecast
  12.1. Introduction
  12.2. Key Findings
  12.3. Market Value Forecast, by Product Type, 2020-2034
  12.3.1. Instruments
  12.3.2. Consumables
  12.4. Market Value Forecast, by Test Type, 2020-2034
  12.4.1. Prothrombin Time (PT)
  12.4.2. Activated Partial Thromboplastin Clotting Time (APTT)
  12.4.3. Thrombin Time (TT)
  12.4.4. Activated Clotting Time (ACT)
  12.4.5. Others
  12.5. Market Value Forecast, by End-user, 2020-2034
  12.5.1. Hospitals and Clinics
  12.5.2. Diagnostic Laboratories
  12.5.3. Home Care Settings
  12.5.4. Others
  12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
  12.6.1. China
  12.6.2. Japan
  12.6.3. India
  12.6.4. Australia & New Zealand
  12.6.5. Rest of Asia Pacific
  12.7. Market Attractiveness Analysis
  12.7.1. By Product Type
  12.7.2. By Test Type
  12.7.3. By End-user
  12.7.4. By Country/Sub-region
13. Latin America Coagulation Testing Market Analysis and Forecast
  13.1. Introduction
  13.2. Key Findings
  13.3. Market Value Forecast, by Product Type, 2020-2034
  13.3.1. Instruments
  13.3.2. Consumables
  13.4. Market Value Forecast, by Test Type, 2020-2034
  13.4.1. Prothrombin Time (PT)
  13.4.2. Activated Partial Thromboplastin Clotting Time (APTT)
  13.4.3. Thrombin Time (TT)
  13.4.4. Activated Clotting Time (ACT)
  13.4.5. Others
  13.5. Market Value Forecast, by End-user, 2020-2034
  13.5.1. Hospitals and Clinics
  13.5.2. Diagnostic Laboratories
  13.5.3. Home Care Settings
  13.5.4. Others
  13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
  13.6.1. Brazil
  13.6.2. Mexico
  13.6.3. Rest of Latin America
  13.7. Market Attractiveness Analysis
  13.7.1. By Product Type
  13.7.2. By Test Type
  13.7.3. By End-user
  13.7.4. By Country/Sub-region
14. Middle East & Africa Coagulation Testing Market Analysis and Forecast
  14.1. Introduction
  14.2. Key Findings
  14.3. Market Value Forecast, by Product Type, 2020-2034
  14.3.1. Instruments
  14.3.2. Consumables
  14.4. Market Value Forecast, by Test Type, 2020-2034
  14.4.1. Prothrombin Time (PT)
  14.4.2. Activated Partial Thromboplastin Clotting Time (APTT)
  14.4.3. Thrombin Time (TT)
  14.4.4. Activated Clotting Time (ACT)
  14.4.5. Others
  14.5. Market Value Forecast, by End-user, 2020-2034
  14.5.1. Hospitals and Clinics
  14.5.2. Diagnostic Laboratories
  14.5.3. Home Care Settings
  14.5.4. Others
  14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
  14.6.1. GCC Countries
  14.6.2. South Africa
  14.6.3. Rest of Middle East & Africa
  14.7. Market Attractiveness Analysis
  14.7.1. By Product Type
  14.7.2. By Test Type
  14.7.3. By End-user
  14.7.4. By Country/Sub-region
15. Competition Landscape
  15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
  15.2. Market Share Analysis, by Company (2023)
  15.3. Company Profiles
  15.3.1. F. Hoffmann-La Roche Ltd.
  15.3.1.1. Company Overview
  15.3.1.2. Product Portfolio
  15.3.1.3. SWOT Analysis
  15.3.1.4. Financial Overview
  15.3.1.5. Strategic Overview
  15.3.2. Abbott
  15.3.2.1. Company Overview
  15.3.2.2. Product Portfolio
  15.3.2.3. SWOT Analysis
  15.3.2.4. Financial Overview
  15.3.2.5. Strategic Overview
  15.3.3. Siemens Healthineers
  15.3.3.1. Company Overview
  15.3.3.2. Product Portfolio
  15.3.3.3. SWOT Analysis
  15.3.3.4. Financial Overview
  15.3.3.5. Strategic Overview
  15.3.4. Sysmex Corporation
  15.3.4.1. Company Overview
  15.3.4.2. Product Portfolio
  15.3.4.3. SWOT Analysis
  15.3.4.4. Financial Overview
  15.3.4.5. Strategic Overview
  15.3.5. Universal Biosensors, Inc.
  15.3.5.1. Company Overview
  15.3.5.2. Product Portfolio
  15.3.5.3. SWOT Analysis
  15.3.5.4. Financial Overview
  15.3.5.5. Strategic Overview
  15.3.6. HemoSonics, LLC
  15.3.6.1. Company Overview
  15.3.6.2. Product Portfolio
  15.3.6.3. SWOT Analysis
  15.3.6.4. Financial Overview
  15.3.6.5. Strategic Overview
  15.3.7. Thermo Fisher Scientific Inc.
  15.3.7.1. Company Overview
  15.3.7.2. Product Portfolio
  15.3.7.3. SWOT Analysis
  15.3.7.4. Financial Overview
  15.3.7.5. Strategic Overview
  15.3.8. Randox Laboratories Ltd.
  15.3.8.1. Company Overview
  15.3.8.2. Product Portfolio
  15.3.8.3. SWOT Analysis
  15.3.8.4. Financial Overview
  15.3.8.5. Strategic Overview
  15.3.9. Horiba, Ltd.
  15.3.9.1. Company Overview
  15.3.9.2. Product Portfolio
  15.3.9.3. SWOT Analysis
  15.3.9.4. Financial Overview
  15.3.9.5. Strategic Overview
  15.3.10. Agappe Diagnostics Ltd.
  15.3.10.1. Company Overview
  15.3.10.2. Product Portfolio
  15.3.10.3. SWOT Analysis
  15.3.10.4. Financial Overview
  15.3.10.5. Strategic Overview
  15.3.11. Medtronic
  15.3.11.1. Company Overview
  15.3.11.2. Product Portfolio
  15.3.11.3. SWOT Analysis
  15.3.11.4. Financial Overview
  15.3.11.5. Strategic Overview
  15.3.12. Helena Laboratories, Inc.
  15.3.12.1. Company Overview
  15.3.12.2. Product Portfolio
  15.3.12.3. SWOT Analysis
  15.3.12.4. Financial Overview
  15.3.12.5. Strategic Overview

$5,795
$8,795
$11,795

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings